Multi–drug-resistant Tuberculosis (MDR TB):

ˇ         Multi–drug-resistant Tuberculosis (MDR TB): a comprehensive review - http://www.emedicine.com/emerg/topic618.htm

ˇ         WHO: MDR TB: Frequently asked questions (FAQ's) - http://www.who.int/tb/dots/dotsplus/faq/en/index.html

ˇ         WHO: Guidelines for the programmatic management of drug-resistant tuberculosis - http://whqlibdoc.who.int/publications/2006/9241546956_eng.pdf

ˇ        WHO and the International Union Against Tuberculosis and Lung Disease: Guidelines for surveillance of drug resistance in tuberculosis - http://whqlibdoc.who.int/publications/2003/9241546336.pdf

ˇ         WHO: DOTS-Plus and the Green Light Committee - http://www.who.int/tb/dots/dotsplus/management/en/index.html

ˇ         WHO: Procurement manual for the Dots-Plus Projects Approved by the Green Light Committee - http://whqlibdoc.who.int/hq/2004/WHO_HTM_TB_2003.328_Rev.1.pdf

ˇ         WHO: Instructions for applying to the Green Light Committee for access to Second-line Antituberculosis Drugs - http://whqlibdoc.who.int/hq/2001/WHO_CDS_TB_2001.286_Rev.1.pdf

Pulmonary TB & HIV:


Lab Studies:

Tuberculin Skin Test:

Acid-fast bacillus (AFB) smear, and culture and sensitivity (C/S) test:

Chest X-Ray:

Lung Function Tests:

Infant Pulmonary Function Testing:

Diagnostic Flexible Bronchoscopy:

Bronchoalveolar Lavage (BAL):

Gastric Lavage:

Biopsy and Histopathology:


Prevention of Tuberculosis:

Discharge Planning for the Respiratory Care Patient:

Document Provenance and History

Document Author: Dr. Fazal Danish

Document Created: 11th April 2006

Document Edits: